Quick Comparison
| Gotu Kola | Nicotine | |
|---|---|---|
| Half-Life | 2-4 hours (asiaticoside, madecassoside) | 1-2 hours |
| Typical Dosage | Standard: 500-1000 mg standardized extract daily (triterpenes: asiaticoside, madecassoside). Traditional dose: 1-2 grams dried herb as tea. ECa 233 is a well-studied standardized extract. Can be taken morning or evening — mild enough for bedtime use. | Nootropic dose: 1-2 mg via gum, lozenge, or patch. Start with 0.5-1 mg if nicotine-naive. Patch: 7 mg patch cut into quarters (1.75 mg each). Use intermittently (2-3 times per week maximum) to avoid dependence. |
| Administration | Oral (capsules, extract, tea, tincture). ECa 233 standardized extract for consistent dosing. | Transdermal (patch), buccal (gum, lozenge), nasal (spray). Avoid smoking and vaping — the delivery method matters for health. |
| Research Papers | 9 papers | 10 papers |
| Categories |
Mechanism of Action
Gotu Kola
Triterpene saponins (asiaticoside, madecassoside, asiatic acid, madecassic acid) are the primary bioactives. They increase BDNF expression in the hippocampus via CREB and ERK/MAPK pathways, promoting neuroplasticity, synaptogenesis, and memory formation. They enhance collagen type I synthesis through stimulation of fibroblasts and improve microcirculation via VEGF and angiopoietin modulation. Anxiolytic effects occur through positive allosteric modulation of GABA-A receptors (possibly at the benzodiazepine or neurosteroid site) and reduction of acoustic startle response (amygdala modulation). Gotu kola inhibits acetylcholinesterase (AChE), mildly increasing synaptic acetylcholine. Anti-inflammatory effects come from NF-kB inhibition (IkB stabilization) and TNF-alpha suppression. Asiatic acid may also activate PPAR-gamma.
Nicotine
Nicotine binds to nicotinic acetylcholine receptors (nAChRs), particularly the high-affinity alpha-4-beta-2 subtype predominant in the brain, causing conformational changes that open the cation channel and allow Na+ and Ca2+ influx, depolarizing the neuron. This triggers vesicular release of dopamine (VTA to nucleus accumbens and prefrontal cortex), norepinephrine (locus coeruleus), acetylcholine (basal forebrain), serotonin, and glutamate. Cognitive enhancement comes from increased acetylcholine in the prefrontal cortex and hippocampus (attention, working memory) and dopamine in mesocortical pathways (motivation, executive function). Nicotine upregulates BDNF through nAChR-mediated Ca2+ signaling and CREB activation, and has anti-inflammatory effects via microglial alpha-7 nAChRs. Neuroprotection may involve reduced excitotoxicity and enhanced neuronal survival pathways.
Risks & Safety
Gotu Kola
Common
Very well-tolerated. Mild GI upset, drowsiness.
Serious
Rare hepatotoxicity reported — avoid with liver disease and limit use to 6-week cycles.
Rare
Headache, dizziness, skin sensitivity to sunlight.
Nicotine
Common
Nausea, dizziness, hiccups, jaw soreness (gum), skin irritation (patch). Addictive with daily use.
Serious
Cardiovascular strain — increases heart rate and blood pressure. Avoid with cardiovascular disease. Nicotine toxicity at high doses (>60 mg).
Rare
Seizures at toxic doses, severe allergic reactions.
Full Profiles
Gotu Kola →
Centella asiatica is an Ayurvedic and Chinese medicine herb known as the 'herb of longevity.' It has been used for centuries to enhance memory, promote wound healing, and reduce anxiety. Modern research confirms it increases BDNF, enhances collagen synthesis, improves microcirculation, and has anxiolytic effects. Unlike most adaptogens, gotu kola has clinical evidence for improving memory and attention in healthy adults.
Nicotine →
Nicotine — independent of tobacco — is one of the most potent cognitive enhancers known. It enhances attention, working memory, reaction time, and fine motor skills within minutes. Research shows it is neuroprotective and may reduce the risk of Parkinson's disease. Available as gum, patches, and lozenges for non-smokers seeking cognitive benefits without any tobacco exposure.